Results 161 to 170 of about 359,306 (210)

Accuracy of screening tests for cervical precancer in women living with HIV in low-resource settings: a paired prospective study in Lusaka, Zambia. [PDF]

open access: yesBMJ Oncol
Taghavi K   +11 more
europepmc   +1 more source

Smoking, Cervical Precancer and Cancer

Indian Journal of Gynecologic Oncology, 2021
Cervical cancer (CC) is the fourth most common cancer in women worldwide. There is a large body of evidence which shows that smoking interferes with incidence and prevalence of HPV infection and is associated with cervical intraepithelial neoplasia (CIN) and invasive CC.
Padma Eedarapalli   +2 more
openaire   +1 more source

Semi-Supervised Learning for Cervical Precancer Detection

2021 IEEE 34th International Symposium on Computer-Based Medical Systems (CBMS), 2021
Convolutional neural networks have become the paradigm of choice for medical image classification applications. Recent research results have demonstrated that deep learning can provide a promising solution for cervical precancer, which is the direct precursor to invasive cervical cancer.
Sandeep Angara   +3 more
openaire   +2 more sources

Functional biomarkers in cervical precancer: An overview

Diagnostic Cytopathology, 2010
AbstractCervical cancer develops over a long time through precursor lesions that can be detected by cytological screening. Majority of these lesions regress spontaneously. Therefore, the challenge of cervical cancer screening is to detect the lesions that have a high risk of progression. Several promising biomarkers have been described that may improve
Nalini, Gupta   +2 more
openaire   +2 more sources

Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening Research

Cancer Prevention Research, 2023
AbstractDeepening understanding of cervical cancer pathogenesis has yielded one-dose prophylactic human papillomavirus (HPV) vaccines and accurate HPV-based cervical screening tests. Knowing the heterogeneous carcinogenic potential of the individual high-risk HPV types permits prioritization of vaccination and screening strategies.
Kanan T. Desai   +2 more
openaire   +2 more sources

Management of Cervical Precancers: A Global Perspective

Hematology/Oncology Clinics of North America, 2012
Cervical cancer incidence and mortality have decreased dramatically over the past 50 years in countries with access and resources to provide frequent screening, evaluation, and treatment of high-grade cervical cancer precursors. For countries with fewer resources and many competing health concerns, cervical cancer remains one of the most lethal and ...
Daniel, Echelman, Sarah, Feldman
openaire   +2 more sources

200 years of diagnosis and treatment of cervical precancer

European Journal of Obstetrics & Gynecology and Reproductive Biology, 2020
The history of the diagnosis and treatment of cervical precancer is fragmentary. Findings in the English-speaking and German-speaking areas vary considerably. We aim to describe the history of clinical advances in diagnosis and treatment of cervical precancer and identify areas where further work is required.We conducted a search of PubMed and Google ...
Olaf, Reich, Hellmuth, Pickel
openaire   +2 more sources

Biomarkers in Cervical Precancer Management: The New Frontiers

Future Oncology, 2008
The major cause of cervical cancer and its pre-invasive lesions is persistent infections with oncogenic human papillomavirus (HPV). Viral replication and integration in the cervix depends on the ordered expression of viral gene products, which can lead to overexpression of multiple molecular proteins or biomarkers.
Ashfaq M, Khan, Albert, Singer
openaire   +2 more sources

Home - About - Disclaimer - Privacy